Literature DB >> 3184418

The dot plot. A starting point for evaluating test performance.

A F Krieg1, J R Beck, M B Bongiovanni.   

Abstract

We suggest that evaluations of diagnostic tests start with dot plots that depict multiple test results over multiple clinical states. From this starting point we can calculate posttest probabilities for multiple clinical states at multiple test results. Also, we can project one subset of clinical states as "disease positive" and a second subset as "disease negative" to provide standard analyses such as likelihood ratios, relative operating characteristic curves, posttest/pretest probability plots, sensitivity, specificity, and predictive value. Finally, this starting point provides an excellent basis for comparing multiple studies of diagnostic performance. The advantages of dot plots are illustrated with data on serum ferritin levels over multiple clinical states.

Mesh:

Substances:

Year:  1988        PMID: 3184418     DOI: 10.1001/jama.260.22.3309

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  3 in total

1.  Murine monoclonal antibodies against Escherichia coli O4 lipopolysaccharide and H5 flagellin.

Authors:  M Rivera-Betancourt; J E Keen
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

2.  Murine monoclonal antibodies specific for lipopolysaccharide of Escherichia coli O26 and O111.

Authors:  M Rivera-Betancourt; J E Keen
Journal:  Appl Environ Microbiol       Date:  2000-09       Impact factor: 4.792

3.  Evaluation of an epitope-blocking enzyme-linked immunosorbent assay for the diagnosis of West Nile virus infections in humans.

Authors:  M A Loroño-Pino; J A Farfan-Ale; B J Blitvich; J L Beebe; R G Jarman; B J Beaty
Journal:  Clin Vaccine Immunol       Date:  2009-03-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.